Germidine
Internal ID | 59d6ee27-97c3-4b57-aa43-0118a7bfc25f |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal alkaloids > Cerveratrum-type alkaloids |
IUPAC Name | [(1S,2S,6S,9S,10S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23R,25R)-22-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-13-yl] (2R)-2-methylbutanoate |
SMILES (Canonical) | CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(CC6C7(C5(C4)OC6(C(CC7)OC(=O)C)O)C)O)O)O |
SMILES (Isomeric) | CC[C@@H](C)C(=O)O[C@H]1[C@@H]([C@H]2[C@@H](CN3C[C@H](CC[C@H]3[C@@]2(C)O)C)[C@H]4[C@@]1([C@@H]5[C@@H](C[C@H]6[C@]7([C@]5(C4)O[C@]6([C@H](CC7)OC(=O)C)O)C)O)O)O |
InChI | InChI=1S/C34H53NO10/c1-7-17(3)29(39)44-28-26(38)25-19(15-35-14-16(2)8-9-23(35)31(25,6)40)20-13-32-27(33(20,28)41)21(37)12-22-30(32,5)11-10-24(43-18(4)36)34(22,42)45-32/h16-17,19-28,37-38,40-42H,7-15H2,1-6H3/t16-,17+,19-,20-,21+,22-,23-,24-,25+,26+,27+,28-,30-,31+,32+,33-,34+/m0/s1 |
InChI Key | OPCXCFMPHIBOMS-ROYCHNIZSA-N |
Popularity | 3 references in papers |
Molecular Formula | C34H53NO10 |
Molecular Weight | 635.80 g/mol |
Exact Mass | 635.36694689 g/mol |
Topological Polar Surface Area (TPSA) | 166.00 Ų |
XlogP | 1.50 |
Atomic LogP (AlogP) | 1.35 |
H-Bond Acceptor | 11 |
H-Bond Donor | 5 |
Rotatable Bonds | 4 |
Germidin |
UNII-966H80OZVS |
966H80OZVS |
Germidine (alkaloid) |
4-21-00-06802 (Beilstein Handbook Reference) |
BRN 0073452 |
465-77-0 |
C34H53NO10 |
C34-H53-N-O10 |
Cevane-3-beta,4-beta,7-alpha,14,15-alpha,16-beta,20-heptol, 4,9-epoxy-, 3-acetate 15-(+-)-2-methylbutyrate) |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.6715 | 67.15% |
Caco-2 | - | 0.8267 | 82.67% |
Blood Brain Barrier | + | 0.7250 | 72.50% |
Human oral bioavailability | - | 0.7000 | 70.00% |
Subcellular localzation | Lysosomes | 0.6149 | 61.49% |
OATP2B1 inhibitior | - | 0.7179 | 71.79% |
OATP1B1 inhibitior | + | 0.9012 | 90.12% |
OATP1B3 inhibitior | + | 0.9480 | 94.80% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.6374 | 63.74% |
P-glycoprotein inhibitior | + | 0.6672 | 66.72% |
P-glycoprotein substrate | + | 0.6406 | 64.06% |
CYP3A4 substrate | + | 0.7365 | 73.65% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7867 | 78.67% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | - | 0.9078 | 90.78% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | - | 0.9308 | 93.08% |
CYP1A2 inhibition | - | 0.9425 | 94.25% |
CYP2C8 inhibition | + | 0.6476 | 64.76% |
CYP inhibitory promiscuity | - | 0.9613 | 96.13% |
UGT catelyzed | - | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5302 | 53.02% |
Eye corrosion | - | 0.9891 | 98.91% |
Eye irritation | - | 0.9227 | 92.27% |
Skin irritation | - | 0.7598 | 75.98% |
Skin corrosion | - | 0.9349 | 93.49% |
Ames mutagenesis | - | 0.6301 | 63.01% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.5073 | 50.73% |
Micronuclear | + | 0.5500 | 55.00% |
Hepatotoxicity | + | 0.5166 | 51.66% |
skin sensitisation | - | 0.8817 | 88.17% |
Respiratory toxicity | + | 0.6556 | 65.56% |
Reproductive toxicity | + | 0.9000 | 90.00% |
Mitochondrial toxicity | + | 0.9750 | 97.50% |
Nephrotoxicity | + | 0.6358 | 63.58% |
Acute Oral Toxicity (c) | I | 0.8149 | 81.49% |
Estrogen receptor binding | + | 0.6859 | 68.59% |
Androgen receptor binding | + | 0.7620 | 76.20% |
Thyroid receptor binding | - | 0.6110 | 61.10% |
Glucocorticoid receptor binding | + | 0.5792 | 57.92% |
Aromatase binding | + | 0.6954 | 69.54% |
PPAR gamma | + | 0.6740 | 67.40% |
Honey bee toxicity | - | 0.6899 | 68.99% |
Biodegradation | - | 0.7000 | 70.00% |
Crustacea aquatic toxicity | + | 0.5045 | 50.45% |
Fish aquatic toxicity | + | 0.7302 | 73.02% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.53% | 97.25% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.51% | 96.09% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 97.40% | 89.05% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 96.00% | 85.14% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 95.58% | 96.77% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.72% | 94.45% |
CHEMBL2581 | P07339 | Cathepsin D | 93.17% | 98.95% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 92.58% | 82.69% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 92.16% | 95.89% |
CHEMBL299 | P17252 | Protein kinase C alpha | 91.78% | 98.03% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 91.76% | 95.00% |
CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 91.50% | 95.36% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 90.97% | 97.79% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.67% | 97.14% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 89.61% | 97.09% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 89.35% | 86.33% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.21% | 100.00% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.36% | 89.50% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 87.48% | 97.28% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 87.05% | 94.00% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 85.73% | 82.50% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 85.40% | 92.50% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 84.96% | 99.17% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 84.52% | 93.56% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 83.82% | 97.31% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 83.51% | 95.50% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 83.44% | 100.00% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 83.16% | 96.47% |
CHEMBL204 | P00734 | Thrombin | 83.15% | 96.01% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 83.02% | 89.00% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.91% | 93.00% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 82.78% | 100.00% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 82.40% | 100.00% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 82.22% | 95.89% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 81.75% | 96.90% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 81.50% | 98.05% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 80.92% | 90.71% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 80.56% | 97.50% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.55% | 91.19% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 80.26% | 91.03% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 80.13% | 94.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Artemisia lagocephala |
Tanacetum parthenium |
Veratrum nigrum |
PubChem | 90478953 |
NPASS | NPC8605 |
LOTUS | LTS0090574 |
wikiData | Q27271870 |